773 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Novartis Tests New Alzheimer's Drugs on People Who Don't Have the Disease https://www.wsj.com/articles/novartis-tests-new-alzheimers-drug-on-people-who-dont-have-the-disease-1492871315?mod=pls_whats_news_us_business_f Apr 23, 2017 - Subjects at high risk of developing Alzheimer’s—but who don’t actually have the disease—are being recruited to help test two experimental treatments from Novartis AG, in a new focus on preventive treatment.
Read This Before You Buy Biotech Stocks https://www.fool.com/investing/2017/04/23/read-this-before-you-buy-biotech-stocks.aspx?source=iedfolrf0000001 Apr 23, 2017 - Looking to buy biotech stocks? Here are 7 important things to know.
Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again? http://www.zacks.com/stock/news/257309/amgen-amgn-to-report-q1-earnings-will-it-beat-again?cid=CS-ZC-FT-257309 Apr 21, 2017 - We expect biotech major Amgen Inc. (AMGN) to beat expectations when it reports first-quarter 2017 results on Apr 26 after the market closes.
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/257090/eli-lilly-lly-to-report-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-257090 Apr 20, 2017 - Eli Lilly and Company (LLY) will report first-quarter 2017 results on Apr 25, before the market opens.
Novartis (NVS) Q1 Earnings: Will the Stock Disappoint? http://www.zacks.com/stock/news/257089/novartis-nvs-q1-earnings-will-the-stock-disappoint?cid=CS-ZC-FT-257089 Apr 20, 2017 - Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report first-quarter 2017 results on Apr 25.
What's in Store for Biogen (BIIB) this Earnings Season? http://www.zacks.com/stock/news/257086/whats-in-store-for-biogen-biib-this-earnings-season?cid=CS-ZC-FT-257086 Apr 20, 2017 - Biogen Inc. (BIIB), a well-known name in the multiple sclerosis (MS) market, will report first-quarter 2017 results on Apr 25, before the market opens.
What's in the Cards for Centene (CNC) this Earnings Season? http://www.zacks.com/stock/news/257062/whats-in-the-cards-for-centene-cnc-this-earnings-season?cid=CS-ZC-FT-257062 Apr 20, 2017 - Centene Corporation (CNC)will release first-quarter 2017 results on Apr 25, before the market opens.
Is J&J's Pharma Sales Slowdown a Warning for Other Players? http://www.zacks.com/stock/news/256931/is-jjs-pharma-sales-slowdown-a-warning-for-other-players?cid=CS-ZC-FT-256931 Apr 19, 2017 - Johnson & Johnson (JNJ) reported mixed first-quarter 2017 earnings results on Tuesday.
The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe's, Bristol-Myers and Priceline http://www.zacks.com/stock/news/256604/the-zacks-analyst-blog-highlights-alphabet-amgen-lowe%92s-bristol-myers-and-priceline?cid=CS-ZC-FT-256604 Apr 18, 2017 - The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe’s, Bristol-Myers and Priceline
Top Research Reports for Alphabet, Amgen & Lowe's http://www.zacks.com/research-daily/110315/top-research-reports-for-alphabet-amgen-lowes?cid=CS-ZC-FT-110315 Apr 17, 2017 - Top Research Reports for Alphabet, Amgen & Lowe's

Pages: 1...6263646566676869707172...78

<<<Page 67>